View Older Stories View More Recent Stories

Feb 13, 2025 08:30AM Intelligent Bio Solutions Announces Fiscal Q2 2025 Financial Results and Key Operational Achievements
Feb 10, 2025 08:30AM Intelligent Bio Solutions Releases Shareholder Letter Detailing 2024 Growth and 2025 U.S. Expansion Strategy
Feb 7, 2025 08:33AM Intelligent Bio Solutions (INBS) Expands with UK Partnership
Feb 7, 2025 08:30AM Intelligent Bio Solutions Expands with UK Partnership, Driving Global Growth Ahead of Planned U.S. Launch
Feb 6, 2025 09:00AM Intelligent Bio Solutions expects to achieve 32.6% Gross Profit Expansion and Increased Profitability on Higher-Margin Sales
Jan 31, 2025 09:00AM Intelligent Bio Solutions (INBS) Expands Global Reach with Multilingual Drug Screening System Upgrade
Jan 31, 2025 09:00AM Intelligent Bio Solutions Expands Global Reach with Multilingual Drug Screening System Upgrade
Jan 30, 2025 09:00AM Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029
Jan 29, 2025 09:10AM Intelligent Bio Solutions (INBS) Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing
Jan 29, 2025 09:00AM Intelligent Bio Solutions Adds Quantum TM to 400+ Account Portfolio Utilizing Breakthrough Fingerprint Drug Testing
Jan 28, 2025 09:00AM Intelligent Bio Solutions Partners with IVY Diagnostics to Expand in Europe’s $3.6 Billion Drug Screening Market and in Middle Eastern Regions
Jan 14, 2025 08:30AM Intelligent Bio Solutions Partners with Princebuild to Transition from Saliva Testing to Fingerprint Sweat-Based Drug Screening Across its Seven UK Sites
Dec 18, 2024 08:31AM Intelligent Bio Solutions (INBS) Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology
Dec 18, 2024 08:30AM Intelligent Bio Solutions Announces 510(k) Submission to US FDA for Fingerprint Sweat-Based Drug Screening Technology
Nov 26, 2024 08:31AM Intelligent Bio Solutions (INBS) Achieves 94.1% Accuracy in Method Comparison Study
Nov 26, 2024 08:30AM Intelligent Bio Solutions Achieves 94.1% Accuracy in Method Comparison Study, Following Positive PK Study Results
Nov 13, 2024 08:35AM Intelligent Bio Solutions (INBS) Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission
Nov 13, 2024 08:30AM Intelligent Bio Solutions Announces Positive Results of PK Study, a Key Milestone on Path to FDA 510(k) Submission
Nov 7, 2024 08:30AM Intelligent Bio Solutions Reports Fiscal 2025 First Quarter Financial Results and Operational Highlights
Oct 31, 2024 08:34AM Intelligent Bio Solutions (INBS) Partners with B2i Digital to Amplify Investor Outreach
Oct 31, 2024 08:30AM Intelligent Bio Solutions Partners with B2i Digital to Amplify Investor Outreach
Oct 29, 2024 08:31AM Intelligent Bio Solutions (INBS) Reports Prelim Q1 Results
Oct 29, 2024 08:30AM Intelligent Bio Solutions Announces Preliminary Unaudited Fiscal 2025 First Quarter Revenue Results
Oct 24, 2024 08:30AM Intelligent Bio Solutions Celebrates One Year Anniversary of Enhanced Workplace Safety with London-Based Real-Estate Developer, Mount Anvil
Oct 14, 2024 08:00AM Intelligent Bio Solutions (INBS) Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek
Oct 14, 2024 08:00AM Intelligent Bio Solutions Announces Adoption of its Non-Invasive Drug Screening Solution by Global Engineering Leader, Pyrotek
Oct 1, 2024 08:30AM GPS Marine Adopts Intelligent Bio Solutions’ Fingerprint Drug Testing Technology to Boost Workplace Safety in Maritime Services
Sep 27, 2024 08:32AM Intelligent Bio Solutions (INBS) Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission
Sep 27, 2024 08:30AM Intelligent Bio Solutions Concludes In-Clinic Testing for Clinical Study Plan, Advancing Toward FDA 510(k) Submission
Sep 11, 2024 08:30AM Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Virtual Conference on September 18-19, 2024
Sep 3, 2024 08:30AM Intelligent Bio Solutions Inc. Reports 118% Year-Over-Year Growth in Customer Employee Base, Reaching an Estimated Total of 1.4 Million Employees
Aug 21, 2024 08:31AM Intelligent Bio Solutions (INBS) Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024
Aug 21, 2024 08:30AM Intelligent Bio Solutions Inc. Achieves Major Milestone with Over 1,000 Installed Intelligent Fingerprinting Drug Screening Readers as of June 30, 2024
Aug 13, 2024 08:30AM Intelligent Bio Solutions Inc. Highlights Growing Need for Drug Testing Solutions in Key Industries
Aug 1, 2024 08:30AM Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway
Jul 24, 2024 08:30AM Intelligent Bio Solutions Inc. Announces QabasTech as Exclusive Distributor in Saudi Arabia
Jul 18, 2024 08:37AM Intelligent Bio Solutions (INBS) Advances on FDA 510(k) Pathway with Biocompatibility Study Success
Jul 18, 2024 08:30AM Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success
Jul 9, 2024 08:30AM Intelligent Bio Solutions Strengthens UK Market Position with Addition of Key Manufacturing Accounts
Jun 28, 2024 08:30AM Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
Jun 28, 2024 08:30AM Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results
Jun 27, 2024 08:36AM Intelligent Bio Solutions (INBS) Expands Presence in the UK Retail Sector with Major Account Acquisitions
Jun 27, 2024 08:30AM Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions
Jun 20, 2024 08:30AM Intelligent Bio Solutions Broadens UK Customer Base by Securing Two Key Accounts with Over 70 Locations and Over 15,000 Employees in the Warehouse and Logistics Sector
Jun 18, 2024 08:30AM Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology
Jun 13, 2024 08:30AM Intelligent Bio Solutions Implements Strategic Reorganization Plan to Support Global Growth Initiatives
Jun 12, 2024 08:32AM Intelligent Bio Solutions (INBS) Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
Jun 12, 2024 08:30AM Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology
Jun 6, 2024 08:30AM Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024
May 29, 2024 08:30AM Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study
View More Recent Stories View Older Stories